We have established a unique variant cell line, MC/9.IL-4, which continuously proliferates in the presence of interleukin-4 (IL-4). from a murine interleukin-3 (IL-3)-dependent mast cell line, MC/9 (referred t o as MC/9.IL-3). Compared with MC/9.IL-3 cells, MC/9.IL-4 cells are smaller, lack cytoplasmic granules and metachromasia, carry a very small amount of histamine, and express fewer high-affinity IgE receptors (IgERs) and IL-3 receptors. To further characterize MC/9.IL-4, we developed a novel method t o enrich cell typespecific cDNAs by cDNA library subtraction and applied it for MC/9.IL-3 versus MC19.IL-4. Sequence analysis of cDNA clones isolated by this technique showed that MC/9.IL-4 cells specifically express CD& and expression of mast cellspecific proteases and major histocompatibility complex class II (MHCII) is considerably decreased. It was also noted AST CELLS ARE derived from pluripotent hematopoietic stem cells in bone marrow, and are highly differentiated in tissues such as peritoneum and intestinal mucosa.'.* They express the high-affinity IgE receptor (IgER, Fc,RI) on their cell surface3 and contain secretory granules in their cytoplasm where a carboxypeptidase, several distinct mast cell serine proteases, and histamine are to red.',^,^ Mast cells play a role in the immune and inflammatory reactions, particularly in the allergic reaction and defense against parasitic infection by secreting various kinds of mediators including cytokine~.~~' Because rapid proliferation of mast cells in the intestinal mucosa during parasitic infection does not occur in genetically T-cell-deficient ndnu mice,' T-cell-derived cytokines appear to be involved in the proliferation of mast cells. Until now four such cytokines, interleukin-3 (IL-3), interleukin-4 (IL-4), interleukin-9 (IL-9), and interleukin-10 (K-lo), have been molecularly cloned as growth/differentiation factors for mast IL-3 is a pleiotropic cytokine that stimulates the proliferation and differentiation of hematopoietic stem cells, as well as various lineage-committed hematopoietic progenitors, including pre-B cells, erythroid progenitors, megakaryocytes, macrophages, eosinophils, and mast cell^.'^,'^ L -4 also exhibits diverse activities on a variety of cell types. It induces B-cell proliferation in the presence of anti-IgM antibodies, induces lipopolysaccharide (LPS)-activated B cells to express CD23 and produce IgGl, stimulates T cells, monocytes, macrophages, mast cells, fibroblasts, and endothelial IL-3-dependent immature mast cell lines can be established from murine bone marrow cells in the presence of IL-3. MC/9I7 (MC/9.IL-3 in this study) is one such cell line, and has been widely used to study cytokines, cytokine receptors, cytokine-mediated signal transduction, and mast cell matura-IL-9, and IL-10 are known to stimulate the proliferation of MC/9.IL-3 cells. While IL-3 alone supports long-term proliferation of MCl9.L-3, other cytokines augment the proliferation, and none of these cytokines alone can support 
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This IL-4-dependent MC/9 variant cell line (MU9.K-4) has lost responsiveness to IL-3 due to the loss of the L -3 receptor (IL-3R) expression (T.H. and A.M., submitted). What phenotype does MC/9.IL-4 exhibit? To characterize the cells at the gene expression level, we have developed a novel method to enrich for cell type-specific cDNAs by subtracting a cDNA library from another cDNA library, and we isolated and analyzed several cDNAs that are induced or downregulated in MC/9.IL-4 cells.
MATERIALS AND METHODS
Cell lines, media, andcytokines. A murine IL-3 (mIL-3)-dependent mast cell line, MC/9," and its IL-4-dependent variant cell line, MC/9.IL-4, were grown in RPM1 1640 medium supplemented with 10% fetal calf serum (FCS), 50 pmol/L 2-mercaptoethanol (2"E), and either &L-3 (10 ng/mL), or murine L-4 ( a -4 ) (10 n@mL),
190
respectively. Recombinant mIL-3 and mIL-4 were described previous~y.*o~2' Cell proliferation assay. To detect a short-term response of cells to mIL-4 and F9 antibody, a colorimetric assay using 3-(4,5-dimethyl-thiasol-2-yl)-2,5-diphenyltetrmlium bromide (m) (Sigma, St Louis, MO) was performed as described by Mosmann.z* Briefly, IO4 cells (50 pL) were mixed with 50 pL of various concentrations of mIL-4 or F9 hybridoma supernatant in 96-well plates. After a 2-day culture, 10 pL of MTT (5 mg/mL phosphate-buffered saline [PBS] was added per well and incubated at 37°C for 4 hours before the colorimetric analysis. The F9 hybridoma supernatantz3 was generously provided by Dr M. Furuichi (Nippon Roche, Kanagawa, Japan).
Analyses of mast cell-characteristic properties. Morphological properties of MC/9.IL-4 cells were characterized by staining with May-Griinwald-Giemsa, Alcian blue (pH 0.4), and Safranin. The number of Fc,RI expressed on the cells was estimated by direct binding of 'Z51-labeled mouse IgE.24 Histamine content in the cells was determined by the automated technique of Siraganian2'
Antibodies and jlow-cytometric analysis. Phycoerythrin (PE)-conjugated anti-CD8cu, anti-CD80, and anti-CD4 monoclonal antibodies (MoAbs), Fluorescein isothiocyanate (F1TC)-conjugated anti-CD25 and anti-Thy-l MoAbs were provided by Dr A. Zlotnik (DNAX, Palo Alto, CA). FITC-conjugated murine IgE was provided by S. Hudak (DNAX). Anti-B220/CD45R MoAb (RA3-6B2),*' anti-CD24/heat-stable antigen MoAb (J1 Id)'' and isotype control MoAb were obtained from Pharmingen (San Diego, CA). MoAb against murine major histocompatibility complex class I1 (MHCII) (M5/ 114)'' was obtained from Boehringer Mannheim (Indianapolis, IN). FITC-conjugated anti-rat IgG or IgM antibodies were purchased from Pierce (Rockford, IL). Cells (IO5 to 10' ) were incubated in 50 pL of PBS pH 7.4, containing 5% FCS and PE-or FITC-conjugated MoAb (10 pg/mL) or FITC-conjugated IgE (40 pg/mL), and analyzed by using a FACScan (Becton Dickinson, San Jose, CA). For unconjugated MoAbs, FITC-conjugated corresponding second antibodies ( I O pg/mL) were used.
Construction of directional cDNA libraries. Poly(A)' RNA from MC/9.IL-3 cells or MC/9.IL-4 cells was used to synthesize first-strand cDNA by using the NotYOligo-dT,, primer (Pharmacia, Piscataway, NJ). Double-stranded cDNA was synthesized, ligated with EcoRI adaptors, digested with NotI, size fractionated (> 1.0 kilobase pairs [kbp] ) and ligated into EcoRIINotI sites of pME18S vector, a derivative vector of pCEV4.'' Electro-competent Escherichia coli WM1100 cells (BioRad, Hercules, CA) were used for transformation. Total number of independent clones of the cDNA libraries were 6 X lo5 for MC/9.IL-3 and 1.2 X lo6 for MC19.L 4, respectively.
Library subtraction. The polymerase chain reaction (PCR)-based subtraction system developed by Wang and Brown'" was modified to apply to plasmid cDNA libraries. An MC19.IL-4-specific subtracted library was generated as follows: 40 pg of MC/9.IL-3 cDNA library DNA was digested with EcoRI, NotI, and ScaI (ScaI cleaves the vector) followed by the filling-in reaction with DNA polymerase Klenow fragment. After ethanol precipitation, the DNA was dissolved in 40 pL of HzO, heat-denatured, mixed with 40 pL (40 pg) of Photoprobe biotin (Vector Laboratories, Burlingame, CA). According to the manufacturer's manual, it was irradiated with a 270-W sunlamp on ice for 20 minutes. Additional Photoprobe biotin (20 pL) was added and the biotinylation reaction was repeated. After buthanol extraction, the photobiotinylated DNA (Driver"3) was ethanol-precipitated and dissolved in 32 pL of 10 mmoVL Tris-HC11 1 mmol/L EDTA, pH 8 (TE). As a tracer DNA, I pg of MC19.IL-4 cDNA was digested with EcoRI and NotI, ethanol-precipitated, and dissolved in 4 pL of TE (Tracer"4). Tracer"4 was mixed
with 16 p L of Driver"3, 1 pL (10 pg) of E coli tRNA (Sigma), and 20 pL of 2 X hybridization buffer (1.5 m o m NaCVlO mmol/ L EDTA/5O mmol/L HEPES pH 7.5/0.2% sodium dodecyl sulfate [SDS]), overlaid with mineral oil, and heat-denatured completely. The sample tube was immediately transferred into a 68°C water bath and incubated for 20 hours (long hybridization [LH] ). The reaction mixture was then subjected to the streptavidin treatment followed by phenol/chroloform extraction exactly as described by Wang and Brown." Subtracted DNA was precipitated, dissolved in 12 pL of TE, mixed with 8 pL of Driver"3 and 20 pL of 2 X hybridization buffer, and subjected to a hybridization at 68°C for 2 hours (short hybridization [SH] ). After removal of biotinylated double-stranded DNAs, residual DNA was ligated with 250 ng of a purified fragment (3.0 kbp) of pME18S digested with EcoRI and NotI, and used for transformation of the electro-competent E coli cells to generate first MC/9.IL-4-specific subtracted library (M4-l). The same procedure was performed by using the MC/9.IL-3 library as a tracer and the MC/9.IL-4 library as a driver to produce first MC/9.IL-3-specific subtracted library (M3-1). Second MC/9.IL-4-subtracted library (M4-2) was made from M4-l after LH with M3-I as a driver followed by SH with Driver"3.
Likewise. second MC/9.IL-3-subtracted library (M3-2) was also made from M3-1 by LH with M4-1 as a driver followed by SH with the MC/9.IL-4 library as a driver. Plasmid DNAs were prepared from 100 independent clones, which were randomly picked from each second subtracted cDNA library, and grouped based on the insert size and restriction sites. Representative cDNA clones were further characterized by RNA blot analysis and DNA sequencing.
RNA blot analysis and reverse transcriptase-PCR analysis. Poly(A)+ RNA was prepared from MC/9.IL-3 and MC/9.IL-4 cells by using QuickPrep mRNA purification kit (Pharmacia). RNA blot and hybridization was performed according to the standard method. The cDNA fragments isolated by digestion with EcoRI and Not1 were labeled with 32P by using T7 Quickprimer labeling kit (Pharmacia) and used for probes. As a probe for the detection of 0-actin transcript, a 1.2-kbp PstI fragment of the murine p-actin cDNA, kindly provided by Dr R. De Waal Malefyt (DNAX), was used. Probes for GATA-I and GATA-2 were the 1.8-kbp XhoI fragment of the mouse GATA-1 cDNA and the 2.2-kbp EcoRI fragment of the human GATA-2 cDNA (generous gifts from Dr S. Orkin, Harvard Medical School), respectively. Poly(A)+ RNA was used for reverse transcriptase (RT)-PCR analysis with First-Strand cDNA synthesis kit (Pharmacia) and AmpliTaq DNA polymerase (Perkin Elmer, Norwalk, CT) according to the manufacturers' manuals. Primers to detect mRNA expression of mouse mast cell protease-2 (MMCP-2), mouse mast cell protease-6 (MMCP-6), and mouse GATA-3 were designed based on the published sequence 5"AACGGTT-AGAT-3' for MMCP-2; 5'-CTGCGGAGGCTCTCTCATCCA-3' and 5'-GGAATGCTCAGGGACATAGCG-3' for MMCP-6; 5'-AGTCCTCCAG-3' for GATA-3, respectively. DNA sequencing. Plasmid DNA was denatured, primed with two oligonucleotides, ME-I and ME-4, complementary to sequences located 50 bases upstream and downstream from the cloning site of pME18S, respectively. The samples were subjected to the dideoxynucleotide chain termination reaction by using Sequenase kit (US Biochemical, Cleveland, OH). Sequences of 150 to 250 bp from the 5' terminal of each insert cDNA fragment were determined and searched against GenBank and Eh4BL nucleotide data bases.
CGAAGGAGAGGTGT-3' and 5"CCAGGGCAGGTAATAGG-CAGCTGCCAGATAGCATGAAG-3' and 5"GCTCTTGGGGA-
RESULTS
Establishment of an IL-4-dependent MC/9 variant cell line. MC/9.IL-3 is an L-3-dependent mouse mast cell line, and also proliferates in response to L -4 for a short period of time (Fig 1) . Continuous culture of MC/9.L-3 in medium containing L -4 without IL-3 resulted in death of most of the cells in several days. However, an adapted variant cell population started to grow after a l-month culture. These cells responded to L -4 much more strongly than MC/ 9.L-3 (Fig 1) and have grown continuously in the presence of L -4 for over 2 years. They express approximately twice as many L -4 receptors as the parental cells based on staining with the anti-IL-4 receptor MoAb (data not shown). We designated the variant cell line as MU9.L-4. Interestingly, MC/9.IL-4 cells no longer responded to L -3 due to the loss of L -3 receptor expression (T.H. and A.M., submitted).
Morphologic properties of MC/9.IL-4 cells. The bone marrow-derived mast cells cultured in medium containing L -3 exhibit immature mast cell ~h e n o t y p e : '~,~'~~ they are Alcian blue'/Safranin-, contain small amounts of granule and histamine, contain mast cell-specific secretary granule serine proteases, and exhibit the high-affinity IgER. To examine if MC/9.IL-4 cells possess such characteristics of the cultured mast cells, we compared the morphologic appearance and the histochemical profile between MC/9.IL-3 and MC/9.IL-4 cells. As shown in Fig 2, MC/9 .IL-4 cells were smaller in size and did not contain cytoplasmic granules as seen in MC/9.IL-3 cells, although we observed fine granules in a small percentage of MC/9.IL-4 cells. MC/9.IL-4 cells did not show metachromasia that is characteristic to mast cells. Expression of the high-affinity IgER, as well as production of histamine, was barely detectable in MC/9.IL-4 cells (Table l) . These results suggested that MC/9.IL-4 cells appeared to have lost characteristic properties of the bone marrow-derived mast cells.
Isolation of cell type-specific genes by cDNA library subtraction. To further characterize MC/9.IL-4 cells, we attempted to isolate genes that are specifically expressed in MC/9.IL-4 cells, but not in MC/9.IL-3 cells, and also genes that are downregulated or diminished in MC/9.IL-4 cells. For this purpose, we developed a cDNA library subtraction system ( Fig 3A) and applied it for MC/9.IL-3 cells versus MC/9.IL-4 cells. Directional cDNA libraries were generated by using a plasmid vector from poly(A)' RNA prepared from both cells. The cDNA inserts from one library were released from the vector by restriction enzyme digestion. The mixture of the DNA fragments were photobiotinylated. and hybridized with the other library DNA, which was also digested with restriction enzymes to release the cDNA inserts. After removal of common cDNA species by streptavidin treatment followed by phenol extraction, the remaining DNA fragments were reinserted into the vector and used for producing a subtracted library. As shown in Fig 3B, several enriched cDNA insert bands were visible in the first subtracted libraries and second subtraction resulted in fewer and more prominent bands. We, therefore, isolated individual clones from the second subtracted libraries (M3-2; MC/9.1L-3 cDNA library subtracted twice with MC/9.IL-4 cDNAs, and M4-2; MC/9.IL-4 cDNA library subtracted twice with MC/9.IL-3 cDNAs, see Materials and Methods, and examined their specific expression in either MC/9.IL-3 cells or MC/9.IL-4 cells by Northern blot analysis. Eight of nine genes isolated from M3-2 were MC/9.IL-3-specific, while five of six M4-2-derived genes were specifically expressed in MC/9.IL-4 cells (Fig 4 and data not shown) . We next analyzed the DNA sequences of these 13 cDNA inserts and searched for homologous sequences in the databases. The results are summarized in Table 2 . Nucleotide sequences (150 to 200 bp) of the 5'-end of MC/9.IL-3-specific cDNAs, 3H, M32c1, M32c10, M32c18, M32c47, and M32c63, were identical to published sequences of mast cell carboxy peptidase A (MC-CPA)?' MHCII MHCII A c Y ,~ mouse mast cell protease-5 (MMCP-5),'""* MHCII AD: ' and tryptophan hydroxylase," respectively. One gene, M32c37, was not completely matched to any known sequence. However, it has significant homology with the hu- (Fig 4 and data not shown) . This result is consistent with the histochemical analysis of the cells. Expression of another mast cell serine protease, MMCP-2, was also diminished in MC/9.IL-4 cells based on the RT-PCR analysis. However, the MMCP-6 transcript was detected by this method in both cells (data not shown). Absence of the high-affinity IgER was again confirmed by flowcytometry by using FITC-labeled murine IgE (Fig 5B) . As indicated by the library subtraction, MC/9.IL-3 cells were found to express MHCII, and its expression was considerably decreased in MU9.IL-4 cells. This was also proved by the FACS staining with anti-MHCII complex MoAb, MY1 14 ( Fig 5B) . were also absent in MC/9.IL-4 cells. Because many IL-3-responsive hematopoietic cell lines, including mast cells, have been shown to respond to the agonistic F9 antibody for we examined the responsiveness of MC/ 9.IL-4 cells to the F9 antibody. The F9 antibody seems to recognize a distinct molecule from the cloned IL-3R subunits because the CTLL-2 transfectant expressing two types of the high-affinity IL-3R (CTLWABS C32) cannot proliferate in the presence of F9 antibody (Fig 6) . The MC/9.IL-4 cells were unable to respond to the IL-3 and F9 antibody (Fig 6) . Taken together, our results indicate that MC/9.IL-4 cells have lost many mast cell-related characteristics.
CD8a expression in MC/9..IL-4 cells. To confirm the specific expression of CD80 in MU9.IL-4 cells at the protein level, the cells were stained with anti-CD8a MoAb, as well as MoAbs against other T-cell surface antigens, CDSP, Thy-1 (Fig 5A) , and CD4 (data not shown). Interestingly, MC/ 9.1L-4 cells expressed CD8a but not other T-cell antigens. CD25 and B220, which were expressed in MC/9.IL-3 cells, were retained in MU9.IL-4 cells as well (Fig 5, A and B) . indicating that MC/9.IL-4 still possesses a part of the parental phenotype. This agrees with the expression of a small amount of MC-CPA, MMCP-5, and MMCP-6 in MU9.IL-4 cells. Another antigen found to be differentially expressed in MC/ 9.IL-4 cells was the heat-stable antigen, CD24 (Fig 5B) , which is known to be present in immature thymocytes, pre-B cells, and erythroid cells, but not in mature lymphocytes."
To examine whether the phenotypic change of MC/9.IL-3 to MC/9.IL-4 is reversible, we cultured MC/9.IL-4 cells in the presence of IL-3 without IL-4. Only a few cells survived under this condition. and IL-3-responsive cells were obtained after a 1 -month culture. FACS analysis showed that these IL-3-responsive cells expressed the a and P subunits of IL-3R. but not CD8a and IgER (Fig 7) . This result suggested that the phenotype of MC/9.IL-4 can be partially converted to that of MC/9.IL-3.
Expression of hematopoietic transcription factors. Transcriptional activity of the MC-CPA gene is known to be 2 (3.0-kb mRNA) was only detectable in MC/9.IL-3 cells.
3, was detected in both cells by RT-PCR assay and Northern markable change of the phenotype in MC/9.IL-4 cells could be correlated with downregulation of the hematopoietic transcriution factor GATA-2.
MCB.11-3
Transcript of the other member of the GATA family, GATA-
analysis (data not shown). These results suggested that re-
We have established the IL-4-dependent mast cell-derived cell line, MC/9.IL-4, histochemical analyses. and molecular characterization of this cell line have demonstrated that MC/9.IL-4 cells have lost mast cell-related properties. They, instead, express CD8a and CCPI. both of which are cytotoxic T-cell markers. In the mouse, CD8a and CD8P
Oo0
Ooo0 form the CD8 complex, which is expressed mainly on cyto-F9 dilution (x) toxic T cells and is also involved in interaction with MHC (Table 3) ; and (4) expression of GATA-l , absent in T cells, was found at the level equal to that of MC/9.IL-3 (Fig 8) . As shown by Zon et a!,"' GATA-2 transactivates the transcription of the MC-CPA gene. In addition, the GATA binding motif is found in the S' upstream regions of the transcription initiation sites of the MMCP-S, the rat FER, and the murine IL-3RB genes,'"~s4~s5 all of which were downregulated in MC19.IL-4 cells. In MC/9.IL-3 cells, three members of the GATA gene family, GATA-I , GATA-2, and GATA-3, were expressed (Table 3) . Among them, GATA-2 expression was diminished in MC/9.IL-4 cells (Fig 8) , suggesting that the cell phenotype is due to multiple mutations in various transcription factors. It is more likely that deregulation of a critical gene caused alteration of other transcription factors that led to the phenotypic change of MC/9. The phenotype of MC/9.IL-4 may be aberrant and nonphysiologic. However, another possibility is that MC/9.IL-4 represents a certain stage of primitive mast cell precursors. Morphologic appearance and expression of small amounts of the mast cell proteases may support this hypothesis. However, CCPI, expressed in MC/9.IL-4 but not in MC/9.IL-3, was originally found in cytotoxic T cells stimulated with mitogens. The recent report suggested that CCPI is abundantly present in the IL-3-dependent multipotential myeloid progenitor cell line, FDCPmix, and its expression is downmodulated along granulocytic differentiation." Likewise, CD24, expressed in MC/9.IL-4, but not in MC/9.IL-3, is known to be expressed in immature thymocytes, pre-B cells, and erythroid cells, but not in mature lymphocytes. While these findings are in favor of the hypothesis that MC/9.IL-4 may represent an immature mast cell, it should be noted that known mast cell precursors, as well as multipotential progenitors, respond to IL-3. While physiologic significance of MC/9.IL-4 remains unclear, it is a unique and useful cell line because only a few murine T-cell lines that proliferate continuously in response to IL-4 have been establi~hed,6~.~~ and such an IL-4-dependent non-T hematopoietic cell line has not yet been documented to our knowledge. Because MC/9.IL-4 shows stronger response to IL-4 (Fig l) , and can be maintained in the presence of L -4 , it will be useful for studies of IL-4-mediated signaling mechanisms. It is also suitable as an indicator cell line for detection of IL-4 and other cytokines. As the gene expression pattern is dramatically changed in MC/9.IL-4, and this change may be caused in part by the decreased level of GATA-2, this cell line may be useful to study transcriptional regulation of the mast cell-specific genes including proteases, FccR, and IL-3R.
In this study, we have demonstrated the effective use of the novel cDNA subtraction method to characterize the unknown hematopoietic cell line, MC/9.IL-4. Because this method simply depends on the differential expression of mRNA, it allowed us to find the unusual expression of CD8a in MC/9.IL-4. Compared with the other methods, which have been used for isolating cell type-specific genes, the cDNA library subtraction procedure has several advantages: (1) genes can be isolated quickly (in 2 weeks if cDNA libraries are available); (2) no need for radioactive probes, large amounts of RNA, PCR reaction, or special apparatus for screening; (3) as the cDNA is directionally inserted in the vector, the nucleotide sequence of only about 200 bases from the 5' end allows identification of the gene by computer search against the data bases; (4) plasmid DNAs carrying cDNA inserts can be used for expression in mammalian cells, such as COS cells unless an EcoRI site is present inside their coding regions; and (5) once several cDNA libraries are prepared, this technique may be applied for any combination. As we have demonstrated in this work, expression of unpredictable cell surface antigens may be discovered by the library subtraction rather than by trying different antibodies with limited availability. Although this system may have limitation for cloning low abundant or large cDNA fragments, such as IL-3R and GATA-2 cDNAs, as described earlier, it is useful to find differences between two cell lines at the gene expression level. This technique is applicable for isolating inducible genes, as well as cell type-specific genes, by choosing an appropriate combination of positive and negative cells.
